Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Journey Medical Corp (DERM) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Journey Medical Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1867066.
Total stock buying since 2023: $758,060.
Total stock sales since 2023: $1,043,019.
Total stock option exercises since 2023: $81,250.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 171,748 | $887,225 | 1,250,000 | $81,250 |
2024 | 70,000 | $237,290 | 6,505 | $31,084 | 0 | $0 |
2023 | 204,044 | $520,770 | 76,229 | $124,710 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-08 | 0 | $0 | 0 | $0 | 1,250,000 | $81,250 |
2025-05 | 0 | $0 | 10,100 | $69,082 | 0 | $0 |
2025-03 | 0 | $0 | 160,283 | $811,059 | 0 | $0 |
2025-02 | 0 | $0 | 1,365 | $7,084 | 0 | $0 |
2024-07 | 0 | $0 | 4,055 | $21,897 | 0 | $0 |
2024-03 | 70,000 | $237,290 | 0 | $0 | 0 | $0 |
2024-02 | 0 | $0 | 2,450 | $9,187 | 0 | $0 |
2023-11 | 0 | $0 | 4,245 | $17,878 | 0 | $0 |
2023-10 | 48,000 | $143,040 | 0 | $0 | 0 | $0 |
2023-09 | 156,044 | $377,730 | 0 | $0 | 0 | $0 |
2023-07 | 0 | $0 | 24,839 | $43,715 | 0 | $0 |
2023-05 | 0 | $0 | 44,377 | $57,665 | 0 | $0 |
2023-02 | 0 | $0 | 2,768 | $5,452 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-08-25 | Maraoui Claude (President & CEO) | Option Ex | 1,250,000 | .07 | 81,250 |
2025-05-02 | Alloush Ramsey (COO) | Sale | 2,857 | 6.84 | 19,541 |
2025-05-02 | Maraoui Claude (President & CEO) | Sale | 4,834 | 6.84 | 33,064 |
2025-05-02 | Benesch Joseph (CFO) | Sale | 2,409 | 6.84 | 16,477 |
2025-03-11 | Maraoui Claude (President & CEO) | Sale | 49,271 | 5.01 | 246,847 |
2025-03-07 | Maraoui Claude (President & CEO) | Sale | 14,905 | 5.01 | 74,674 |
2025-03-06 | Maraoui Claude (President & CEO) | Sale | 25,551 | 5.04 | 128,777 |
2025-03-05 | Maraoui Claude (President & CEO) | Sale | 18,147 | 5.13 | 93,094 |
2025-03-04 | Maraoui Claude (President & CEO) | Sale | 28,901 | 5.04 | 145,661 |
2025-03-03 | Maraoui Claude (President & CEO) | Sale | 23,508 | 5.19 | 122,006 |
2025-02-21 | Benesch Joseph (CFO) | Sale | 1,365 | 5.19 | 7,084 |
2024-07-23 | Benesch Joseph (CFO) | Sale | 4,055 | 5.40 | 21,897 |
2024-03-25 | Rosenwald Lindsay A Md | Buy | 10,000 | 3.04 | 30,400 |
2024-03-22 | Smith Justin Adam | Buy | 30,000 | 3.47 | 104,100 |
2024-03-22 | Maraoui Claude (President & CEO) | Buy | 10,000 | 3.48 | 34,790 |
2024-03-22 | Rosenwald Lindsay A Md | Buy | 20,000 | 3.40 | 68,000 |
2024-02-22 | Benesch Joseph (Interim CFO) | Sale | 2,450 | 3.75 | 9,187 |
2023-11-28 | Paley Jeffrey | Sale | 1,745 | 5.22 | 9,108 |
2023-11-08 | Paley Jeffrey | Sale | 255 | 3.76 | 958 |
2023-11-07 | Paley Jeffrey | Sale | 2,245 | 3.48 | 7,812 |
2023-10-13 | Smith Justin Adam | Buy | 33,000 | 2.98 | 98,340 |
2023-10-06 | Paley Jeffrey | Buy | 15,000 | 2.98 | 44,700 |
2023-09-21 | Paley Jeffrey | Buy | 30,000 | 2.97 | 89,100 |
2023-09-06 | Maraoui Claude (President & CEO) | Buy | 26,044 | 2.52 | 65,630 |
2023-09-06 | Rosenwald Lindsay A Md | Buy | 100,000 | 2.23 | 223,000 |
2023-07-24 | Maraoui Claude (President & CEO) | Sale | 20,767 | 1.76 | 36,549 |
2023-07-24 | Benesch Joseph (See Remarks) | Sale | 4,072 | 1.76 | 7,166 |
2023-05-17 | Maraoui Claude (President & CEO) | Sale | 24,377 | 1.34 | 32,665 |
2023-05-16 | Maraoui Claude (President & CEO) | Sale | 20,000 | 1.25 | 25,000 |
2023-02-22 | Benesch Joseph (Interim CFO) | Sale | 2,768 | 1.97 | 5,452 |
Insider trading activities including stock purchases, stock sales, and option exercises of DERM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Journey Medical Corp (symbol DERM, CIK number 1867066) see the Securities and Exchange Commission (SEC) website.